Principles of vaccination and possible development strategies for rational design

Immunology Letters

Volumn 122, Issue 2, 2009, Pages 104-107

  Boog, Claire J P ^a,b  

^a NETHERLANDS VACCINE INSTITUTE   (Netherlands)

^b UTRECHT UNIVERSITY   (Netherlands)

Author keywords

Adjuvant; Correlates of protection (CoP); Delivery; Rational design; Therapeutic vaccines; Vaccination

Indexed keywords

CANCER VACCINE; DIPHTHERIA PERTUSSIS TETANUS VACCINE; HEPATITIS B VACCINE; INFLUENZA VACCINE; MEASLES MUMPS RUBELLA VACCINE; POLIOMYELITIS VACCINE; WART VIRUS VACCINE;

CANCER IMMUNIZATION; CANCER PREVENTION; DIPHTHERIA; DISEASE CONTROL; DRUG DELIVERY SYSTEM; HEPATITIS; HUMAN; INFLUENZA; INFLUENZA VACCINATION; INFLUENZA VIRUS B; MEASLES; MEASLES VACCINATION; MUMPS; POLIOMYELITIS; PRIORITY JOURNAL; REVIEW; SMALLPOX; UTERINE CERVIX CANCER; VACCINATION; HEPATITIS A VIRUS; IMMUNOLOGY; INFECTION CONTROL; ORTHOMYXOVIRUS; PATHOGENICITY; POLIOMYELITIS VIRUS; POXVIRUS; TREATMENT OUTCOME; VIRUS HEPATITIS;

COMMUNICABLE DISEASE CONTROL; DIPHTHERIA; HEPATITIS, VIRAL, HUMAN; HEPATOVIRUS; HUMANS; INFLUENZA, HUMAN; MEASLES; MUMPS; ORTHOMYXOVIRIDAE; POLIOMYELITIS; POLIOVIRUS; POXVIRIDAE; SMALLPOX; TREATMENT OUTCOME; VACCINATION;

EID: 61849176508     PISSN: 01652478     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.imlet.2008.11.014     Document Type: Review

References (11)

1. Trinchieri G., and Sher A. Cooperation of Toll-like receptor signals in innate immune defence. Nat Rev Immunol 7 (2007) 179
2. Pira G.L., Florian Kern F., Gratama J.W., Roederer M., and Manca F. Measurement of antigen specific immune responses: 2006 update. Cytometry B Clin. Cytom. 72 (2007) 77
3. O'Neill D.W., and Bhardwaj N. Armed and ready: how effector T cells deploy in reactive lymph nodes to modulate immunity. Nat Immunol 8 (2007) 679-681
4. Fazilleau N., Eisenbraun M.D., Malherbe L., Ebright J.N., Pogue-Caley R.R., McHeyzer-Williams, et al. Lymphoid reservoirs of antigen-specific memory T helper cells. Nat Immunol 8 (2007) 753
5. van der Zeijst B.A., Dijkman M.I., Luytjes W., van Alphen A.J., and van den Dobbelsteen G.P. On the design of national vaccination programmes. Vaccine 25 16 (2007) 3143
6. Meiring H.D., Soethout E.C., Poelen M.C., Mooibroek D., Hoogerbrugge R., Timmermans H., et al. Stable isotope tagging of epitopes: a highly selective strategy for the identification of major histocompatibility complex class I-associated peptides induced upon viral infection. Mol Cell Proteomics 5 (2006) 90
7. Meiring HD, et al. Curr Protocols Immunol, Suppl 77, 16.3:1-19 [antigen processing and presentation].
8. Kwissa M., Kastun S.P., and Pulendran B. Science of adjuvants. Exp Rev Vaccines 6 (2007) 673
9. Fransen F., Boog C.J.P., van Putten J.P., and van der Ley P. Agonists of Toll-like receptors 3, 4, 7, and 9 are candidates for use as adjuvants in an outer membrane vaccine against Neisseria meningitidis serogroup B. Infect Immun 75 (2007) 5939
10. Kersten G., and Hirschberg H. Needle-free vaccine delivery. Expert Opin Drug Deliv 4 (2007) 459
11. Gulley J.L., Madan R.A., and Arlen P.M. Enhancing efficacy of therapeutic vaccinations by combination with other modalities. Vaccine 25 (2007) B89